}IK;/E~790;+!%%4Q95S%]J6F<?$(PTHR=%/
SYSTEM PROCESSING...
}IK;/E~790;+!%%4Q95S%]J6F<?$(PTHR=%/
SYSTEM PROCESSING...
Posted: 2025-04-08 18:15:20 UTC
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
Status
Last Updated
2025-04-08 18:15:56 UTC
Verified By
Rollup News
A groundbreaking study reports 100% cancer remission in all 12 patients with rectal cancer after treatment with dostarlimab, a monoclonal antibody, without the need for chemotherapy, radiation, or surgery.
Complete cancer remission in all patients
Use of monoclonal antibody dostarlimab
No chemotherapy, radiation, or surgery required
No significant adverse events reported